Ahead of Bristol Myers purchase, Celgene partners with Boston cancer startup
Ahead of Bristol Myers purchase, Celgene partners with Boston cancer startup
Bizjournals
Celgene
drug development
Kyn Therapautics
cancer
Flag link:
Sleep Apnea Device Maker Raises $11.5M with Private Placement
Sleep Apnea Device Maker Raises $11.5M with Private Placement
Medical Devices and Diagnostics Industry
sleep apnea
devices
atrial fibrillation
CPAP
SleePath
Flag link:
Johnson & Johnson Is Trying to Recover From Plunge
Johnson & Johnson Is Trying to Recover From Plunge
Investopedia
JNJ
earnings
Flag link:
Doctors Are Confident That AI Won't Replace Them
Doctors Are Confident That AI Won't Replace Them
Forbes
artificial intelligence
physicians
Flag link:
FDA rejects Immunomedics breast cancer drug, extending long regulatory drought
FDA rejects Immunomedics breast cancer drug, extending long regulatory drought
Stat
Immunomedics
FDA
breast cancer
sacituzumab govitecan
Flag link:
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Eli Lilly
NICE
Verzenio
breast cancer
Flag link:
Brexit and beyond: the challenges ahead for pharma
Brexit and beyond: the challenges ahead for pharma
Pharmaforum
Brexit
UK
Europe
Flag link:
ICER to probe for clinical justification of drug price hikes
ICER to probe for clinical justification of drug price hikes
BioCentury
ICER
drug pricing
Flag link:
Novartis teams up with Oxford researchers to crunch big data into clinical insights
Novartis teams up with Oxford researchers to crunch big data into clinical insights
Endpoints
Novartis
University of Oxford
Vas Narasimhan
machine learning
artificial intelligence
Flag link:
Gilead, Genentech join PhRMA
Gilead, Genentech join PhRMA
BioCentury
PhRMA
Genentech
Gilead Sciences
Flag link:
FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay
FDA’s Gottlieb Adds Confusion to Aimmune’s Claims of Shutdown Delay
Xconomy
Aimmune Therapeutics
FDA
Scott Gottlieb
government shutdown
Flag link:
Boehringer building out biologics manufacturing in China
Boehringer building out biologics manufacturing in China
BioPharma Dive
China
drug manufacturing
Boehringer Ingelheim
biologics
Flag link:
January 17 2019 - Lilly-Loxo Oncology $8B buyout deal put together in 10 days
Flag link:
Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Endpoints
Eli Lilly
Loxo Oncology
M&A
JPMHC 2019
Flag link:
Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Fierce Pharma
Teva Pharmaceutical
Israel
taxes
Flag link:
Microbiome Report for Week Ending 1/12/19
Microbiome Report for Week Ending 1/12/19
CP WIre
microbiome
MD Anderson Cancer Center
4D Pharma
EuropaBio
Flag link:
Microbiome Report for Week Ending 1/12/19
microbiome
Flag link:
Lipocine talks up interim data from small NASH study
Lipocine talks up interim data from small NASH study
Fierce Biotech
Lipocine
NASH
LPCN 1144
clinical trials
Flag link:
Becton Dickinson’s fiscal Q1 prelims beat The Street
Becton Dickinson’s fiscal Q1 prelims beat The Street
Mass Device
Becton Dickinson
earnings
devices
Flag link:
A ‘digital pill’ for cancer patients is rolled out for the first time, in hopes of improving outcomes
A ‘digital pill’ for cancer patients is rolled out for the first time, in hopes of improving outcomes
Stat
digital pill
Proteus Digital Health
colorectal cancer
Flag link:

Pages